772 related articles for article (PubMed ID: 8479150)
21. Genetic origin of lupus in NZB/SWR hybrids: lessons from an intercross study.
Xie S; Li L; Chang S; Sharma R; Kaliyaperumal A; Datta SK; Mohan C
Arthritis Rheum; 2005 Feb; 52(2):659-67. PubMed ID: 15693014
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
23. Contributions of Ea(z) and Eb(z) MHC genes to lupus susceptibility in New Zealand mice.
Vyse TJ; Rozzo SJ; Drake CG; Appel VB; Lemeur M; Izui S; Palmer E; Kotzin BL
J Immunol; 1998 Mar; 160(6):2757-66. PubMed ID: 9510177
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
[TBL] [Abstract][Full Text] [Related]
26. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
27. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.
Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR
J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477
[TBL] [Abstract][Full Text] [Related]
28. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
[TBL] [Abstract][Full Text] [Related]
29. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
30. T cell tolerance to self antigens in New Zealand hybrid mice with lupus-like disease.
Kotzin BL; Kappler JW; Marrack PC; Herron LR
J Immunol; 1989 Jul; 143(1):89-94. PubMed ID: 2786535
[TBL] [Abstract][Full Text] [Related]
31. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
[TBL] [Abstract][Full Text] [Related]
32. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.
Izui S; Higaki M; Morrow D; Merino R
Eur J Immunol; 1988 Jun; 18(6):911-5. PubMed ID: 3260184
[TBL] [Abstract][Full Text] [Related]
33. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
34. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
Okudaira H; Terada E; Okudaira K
Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
36. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes.
Erausquin C; Merino R; Izui S; Fernandez-Sueiro L; Saez F; Fernandez F; Rodriguez-Valverde V; Merino J
Cell Immunol; 1995 Apr; 161(2):207-12. PubMed ID: 7697731
[TBL] [Abstract][Full Text] [Related]
38. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
40. The NZB X SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotypic diversity.
Gavalchin J; Datta SK
J Immunol; 1987 Jan; 138(1):138-48. PubMed ID: 3491155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]